Titre : Bases de données pharmaceutiques

Bases de données pharmaceutiques : Questions médicales fréquentes

{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Bases de données pharmaceutiques : Questions médicales les plus fréquentes", "headline": "Bases de données pharmaceutiques : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Bases de données pharmaceutiques : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-05", "dateModified": "2025-04-30", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Bases de données pharmaceutiques" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Bases de données factuelles", "url": "https://questionsmedicales.fr/mesh/D016208", "about": { "@type": "MedicalCondition", "name": "Bases de données factuelles", "code": { "@type": "MedicalCode", "code": "D016208", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "L01.470.750.750" } } }, "about": { "@type": "MedicalCondition", "name": "Bases de données pharmaceutiques", "alternateName": "Databases, Pharmaceutical", "code": { "@type": "MedicalCode", "code": "D062313", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Michele B Kaufman", "url": "https://questionsmedicales.fr/author/Michele%20B%20Kaufman", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Konstantinos Vezertzis", "url": "https://questionsmedicales.fr/author/Konstantinos%20Vezertzis", "affiliation": { "@type": "Organization", "name": "School of Electrical and Computer Engineering, Biomedical Engineering Laboratory, National Technical University of Athens, Heroon Polytecniou 9, Athens, 15780, Athens, Greece." } }, { "@type": "Person", "name": "George I Lambrou", "url": "https://questionsmedicales.fr/author/George%20I%20Lambrou", "affiliation": { "@type": "Organization", "name": "School of Electrical and Computer Engineering, Biomedical Engineering Laboratory, National Technical University of Athens, Heroon Polytecniou 9, Athens, 15780, Athens, Greece." } }, { "@type": "Person", "name": "Dimitrios Koutsouris", "url": "https://questionsmedicales.fr/author/Dimitrios%20Koutsouris", "affiliation": { "@type": "Organization", "name": "School of Electrical and Computer Engineering, Biomedical Engineering Laboratory, National Technical University of Athens, Heroon Polytecniou 9, Athens, 15780, Athens, Greece." } }, { "@type": "Person", "name": "Piotr Ozieranski", "url": "https://questionsmedicales.fr/author/Piotr%20Ozieranski", "affiliation": { "@type": "Organization", "name": "Department of Social and Policy Sciences, University of Bath, Bath, United Kingdom." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Predicting lifespan-extending chemical compounds for", "datePublished": "2023-07-13", "url": "https://questionsmedicales.fr/article/37450404", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.18632/aging.204866" } }, { "@type": "ScholarlyArticle", "name": "A Molecular Modeling Investigation of the Therapeutic Potential of Marine Compounds as DPP-4 Inhibitors.", "datePublished": "2022-12-13", "url": "https://questionsmedicales.fr/article/36547924", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/md20120777" } }, { "@type": "ScholarlyArticle", "name": "Evaluating the performance of machine-learning regression models for pharmacokinetic drug-drug interactions.", "datePublished": "2022-11-17", "url": "https://questionsmedicales.fr/article/36382697", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/psp4.12884" } }, { "@type": "ScholarlyArticle", "name": "Assessing agreement between population-level administrative pharmaceutical databases and patient-reported medication dispensation in cardiac rehabilitation patients.", "datePublished": "2024-07-23", "url": "https://questionsmedicales.fr/article/39047347", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jeph.2024.202764" } }, { "@type": "ScholarlyArticle", "name": "Physicians' attitudes towards disclosure of payments from pharmaceutical companies in a nationwide voluntary transparency database: a cross-sectional survey.", "datePublished": "2022-06-24", "url": "https://questionsmedicales.fr/article/35750457", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1136/bmjopen-2021-055963" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Sciences de l'information", "item": "https://questionsmedicales.fr/mesh/D007254" }, { "@type": "ListItem", "position": 3, "name": "Mémorisation et recherche des informations", "item": "https://questionsmedicales.fr/mesh/D016247" }, { "@type": "ListItem", "position": 4, "name": "Bases de données comme sujet", "item": "https://questionsmedicales.fr/mesh/D019992" }, { "@type": "ListItem", "position": 5, "name": "Bases de données factuelles", "item": "https://questionsmedicales.fr/mesh/D016208" }, { "@type": "ListItem", "position": 6, "name": "Bases de données pharmaceutiques", "item": "https://questionsmedicales.fr/mesh/D062313" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Bases de données pharmaceutiques - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Bases de données pharmaceutiques", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-04-30", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Bases de données pharmaceutiques", "description": "Comment identifier un médicament dans une base de données ?\nQuelles informations sont disponibles sur les effets secondaires ?\nComment vérifier les interactions médicamenteuses ?\nPeut-on trouver des informations sur les médicaments génériques ?\nComment évaluer l'efficacité d'un médicament ?", "url": "https://questionsmedicales.fr/mesh/D062313?page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Bases de données pharmaceutiques", "description": "Où trouver des informations sur les symptômes liés à un médicament ?\nComment les symptômes sont-ils classés dans les bases ?\nLes bases fournissent-elles des exemples de symptômes ?\nComment les symptômes sont-ils liés aux médicaments ?\nPeut-on trouver des symptômes rares dans les bases ?", "url": "https://questionsmedicales.fr/mesh/D062313?page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Bases de données pharmaceutiques", "description": "Les bases fournissent-elles des conseils de prévention ?\nComment prévenir les interactions médicamenteuses ?\nY a-t-il des recommandations pour les populations à risque ?\nComment les bases aident-elles à la prévention des maladies ?\nPeut-on trouver des stratégies de prévention dans les bases ?", "url": "https://questionsmedicales.fr/mesh/D062313?page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Bases de données pharmaceutiques", "description": "Comment rechercher des traitements dans une base de données ?\nLes bases incluent-elles des protocoles de traitement ?\nComment comparer l'efficacité de différents traitements ?\nPeut-on trouver des alternatives aux traitements ?\nComment les traitements sont-ils mis à jour dans les bases ?", "url": "https://questionsmedicales.fr/mesh/D062313?page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Bases de données pharmaceutiques", "description": "Comment identifier les complications liées à un médicament ?\nLes bases fournissent-elles des études de cas sur les complications ?\nComment les complications sont-elles signalées dans les bases ?\nPeut-on trouver des statistiques sur les complications ?\nComment prévenir les complications médicamenteuses ?", "url": "https://questionsmedicales.fr/mesh/D062313?page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Bases de données pharmaceutiques", "description": "Quels facteurs de risque sont associés aux médicaments ?\nComment les bases évaluent-elles les facteurs de risque ?\nPeut-on trouver des recommandations sur les facteurs de risque ?\nComment les facteurs de risque influencent-ils le traitement ?\nLes bases incluent-elles des informations sur les facteurs de risque environnementaux ?", "url": "https://questionsmedicales.fr/mesh/D062313?page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment identifier un médicament dans une base de données ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Utilisez le nom commercial, le principe actif ou le code ATC pour rechercher." } }, { "@type": "Question", "name": "Quelles informations sont disponibles sur les effets secondaires ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les bases fournissent des listes d'effets indésirables et leur fréquence." } }, { "@type": "Question", "name": "Comment vérifier les interactions médicamenteuses ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Consultez les sections dédiées aux interactions dans les bases de données." } }, { "@type": "Question", "name": "Peut-on trouver des informations sur les médicaments génériques ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les bases de données incluent des informations sur les équivalents génériques." } }, { "@type": "Question", "name": "Comment évaluer l'efficacité d'un médicament ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Recherchez des études cliniques et des revues systématiques dans les bases." } }, { "@type": "Question", "name": "Où trouver des informations sur les symptômes liés à un médicament ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les bases de données listent les symptômes associés aux effets secondaires." } }, { "@type": "Question", "name": "Comment les symptômes sont-ils classés dans les bases ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Ils sont souvent classés par système corporel ou par fréquence d'apparition." } }, { "@type": "Question", "name": "Les bases fournissent-elles des exemples de symptômes ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles incluent des exemples pour chaque médicament et ses effets." } }, { "@type": "Question", "name": "Comment les symptômes sont-ils liés aux médicaments ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Les bases établissent des liens entre médicaments et symptômes rapportés." } }, { "@type": "Question", "name": "Peut-on trouver des symptômes rares dans les bases ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les bases documentent également des effets indésirables rares." } }, { "@type": "Question", "name": "Les bases fournissent-elles des conseils de prévention ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles incluent des recommandations pour éviter les effets indésirables." } }, { "@type": "Question", "name": "Comment prévenir les interactions médicamenteuses ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Consultez les bases pour identifier les médicaments à éviter ensemble." } }, { "@type": "Question", "name": "Y a-t-il des recommandations pour les populations à risque ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les bases fournissent des conseils spécifiques pour les groupes vulnérables." } }, { "@type": "Question", "name": "Comment les bases aident-elles à la prévention des maladies ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Elles offrent des informations sur les médicaments préventifs et leur utilisation." } }, { "@type": "Question", "name": "Peut-on trouver des stratégies de prévention dans les bases ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles incluent des stratégies basées sur des données probantes pour la prévention." } }, { "@type": "Question", "name": "Comment rechercher des traitements dans une base de données ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Utilisez des mots-clés comme le nom du médicament ou la pathologie traitée." } }, { "@type": "Question", "name": "Les bases incluent-elles des protocoles de traitement ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles fournissent des recommandations et des protocoles basés sur des preuves." } }, { "@type": "Question", "name": "Comment comparer l'efficacité de différents traitements ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Consultez les études comparatives et les méta-analyses disponibles." } }, { "@type": "Question", "name": "Peut-on trouver des alternatives aux traitements ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les bases proposent souvent des alternatives thérapeutiques." } }, { "@type": "Question", "name": "Comment les traitements sont-ils mis à jour dans les bases ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Les bases sont régulièrement mises à jour avec les dernières recherches et recommandations." } }, { "@type": "Question", "name": "Comment identifier les complications liées à un médicament ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les bases de données listent les complications possibles et leur fréquence." } }, { "@type": "Question", "name": "Les bases fournissent-elles des études de cas sur les complications ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles incluent des études de cas documentant des complications spécifiques." } }, { "@type": "Question", "name": "Comment les complications sont-elles signalées dans les bases ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Elles sont souvent signalées par des professionnels de santé et des patients." } }, { "@type": "Question", "name": "Peut-on trouver des statistiques sur les complications ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les bases fournissent des données statistiques sur la fréquence des complications." } }, { "@type": "Question", "name": "Comment prévenir les complications médicamenteuses ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les bases offrent des recommandations pour minimiser les risques de complications." } }, { "@type": "Question", "name": "Quels facteurs de risque sont associés aux médicaments ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les bases identifient des facteurs comme l'âge, le sexe et les comorbidités." } }, { "@type": "Question", "name": "Comment les bases évaluent-elles les facteurs de risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Elles utilisent des études épidémiologiques et des données cliniques pour évaluer." } }, { "@type": "Question", "name": "Peut-on trouver des recommandations sur les facteurs de risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les bases fournissent des recommandations pour gérer les facteurs de risque." } }, { "@type": "Question", "name": "Comment les facteurs de risque influencent-ils le traitement ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent modifier le choix du médicament et la posologie recommandée." } }, { "@type": "Question", "name": "Les bases incluent-elles des informations sur les facteurs de risque environnementaux ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent inclure des facteurs environnementaux influençant l'efficacité." } } ] } ] }

Sources (10000 au total)

Assessing agreement between population-level administrative pharmaceutical databases and patient-reported medication dispensation in cardiac rehabilitation patients.

Pharmacoepidemiology has emerged as a crucial field in evaluating the use and effects of medications in large populations to ensure their safe and effective use. This study aimed to assess the agreeme... The study included data from patients referred to the TotalCardiology Rehabilitation CR program, and medication data was available in both TotalCardiology Rehabilitation charts and PIN. The accuracy o... Patient-reported usage was higher for statins (41.6 %) vs. 38.4 %), ACE/ARB, beta-blockers (75.7 %) vs. 73.7 %), DOAC (3.5 %) vs. 2.6 %), and ADP-receptor antagonists (71.0 %) vs. 68.1 %) than if PIN ... The study's results, which show a high level of agreement between PIN and patient self-reporting, affirm the reliability of PIN data as a source for obtaining an accurate assessment of medication use....

Physicians' attitudes towards disclosure of payments from pharmaceutical companies in a nationwide voluntary transparency database: a cross-sectional survey.

To investigate German physicians' attitudes towards and experiences with voluntary disclosure of payments by pharmaceutical companies in a public database and their impact on future decisions for or a... A national cross-sectional survey conducted in 2018 among physicians who voluntarily disclosed at least one payment in the German transparency regulation.... Retrospective paper-pencil questionnaire about attitudes towards and experiences with voluntary payment disclosures in the first (2015) and second (2016) years of the German transparency regulation.... German physicians who disclosed either in the first year only, the second year only, or in both years of the transparency regulation.... (1) The probability to disclose in 2016, predicted by physicians' experience of reactions from others in 2015, descriptive norms and attitudes towards transparency; (2) Frequency and (3) Content of re... Data of 234 respondents were analysed (n=42, 45 and 147 physicians who disclosed in 2015, 2016 or both years, respectively). The probability to disclose in 2016 was not predicted by perceived reaction... While confirmatory analyses did not provide significant results, descriptive analyses showed that participants who voluntarily disclose payments mainly do not experience any reactions towards their di...

Data linkage of two national databases: Lessons learned from linking the Dutch Arthroplasty Register with the Dutch Foundation for Pharmaceutical Statistics.

To provide guidance on data linkage in case of non-unique identifiers, we present a case study linking the Dutch Foundation for Pharmaceutical Statistics and Dutch Arthroplasty Register to investigate... Deterministic data linkage was used. Records were linked on: sex, birthyear, postcode, surgery date, or thromboprophylaxis initiation as a proxy for the surgery date. Different postcodes were used, de... We linked 317,899 arthroplasties on patient postcode/hospital postcode(48%). Linkage on the hospital postcode appeared insufficient. Linkage uncertainty ranged from roughly 30% in all arthroplasties t... After identifier selection, checking data availability and internal validity, assessing representativeness, and externally validating our results we found sufficient linkage quality in the patient-pos...

Cross-Sectional and Longitudinal Associations Between Treatment for Herpes Virus Infection and the Dispensing of Antidementia Medicines: An Analysis of the Australian Pharmaceutical Benefits Scheme Database.

Evidence from previous observational studies suggest that infection by herpes simplex virus (HSV) and varicella zoster virus (VZV) increase the risk of dementia.... To investigate if older adults exposed to HSV treatment have lower risk of dementia than the rest of the population.... We used the 10% Australian Pharmaceutical Benefits Scheme (PBS) database from 2013 to 2022 to ascertain the cross-sectional, time-series and longitudinal association between exposure to HSV treatment ... During the year 2022 6,868 (1.2%) of 559,561 of participants aged 60 years or over were dispensed antidementia agent. The odds ratio (OR) of being dispensed an antidementia agent among individuals dis... The dispensing of antiviral medicines for the treatment of HSV and VZV is consistently, but not conclusively, associated with decreased dispensing of antidementia medicines. This suggests that treatme...